The GIA model is based on the cross-reaction of antibodies produced against arthritogenic epitopes on the G1 domain of the human PG aggrecan (used for arthritis induction) with murine aggrecan leading to severe cartilage destruction and the manifestation of autoimmune arthritis [40]. This evidence concerns the gene ACAN and arthritic joint disease.